首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Milbank quarterly

缩写:MILBANK Q

ISSN:0887-378X

e-ISSN:1468-0009

IF/分区:4.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引783
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Jane M Zhu,Ruth Rowland,Inga Suneson et al. Jane M Zhu et al.
Policy Points Despite the growing role of managed care organizations (MCOs) in financing and delivering behavioral health services in Medicaid, little is known about MCO strategies to overcome critical access barriers and the factors influe...
Constanza Hurtado-Acuna,Michael S Rendall Constanza Hurtado-Acuna
Policy Points The 2015 to 2020 Delaware Contraceptive Access Now (DelCAN) initiative followed other long-acting reversible contraception-focused contraceptive initiatives in Colorado and in St. Louis, Missouri. and preceded statewide contra...
Brendan Saloner Brendan Saloner
Policy Points The role of Medicaid in financing, organizing, and delivering substance use disorder (SUD) treatment has grown tremendously over time owing to expansions of eligibility and a push toward more uniformity in benefits. Current in...
Luke E Barry,Sanjay Basu,May Wang et al. Luke E Barry et al.
Policy Points Evidence suggests Medicaid expansion has improved cardiovascular disease (CVD) outcomes, especially among those of lower socioeconomic status. However, less is known about the cost-effectiveness of Medicaid in achieving these ...
Bomi Kim Hirsch,Kiersten Frobom,Gillian Giglierano et al. Bomi Kim Hirsch et al.
Policy Points The population health research field should develop a synthesized approach to evaluate evidence for an intervention's potential impact on equity. When empirical evidence is lacking, theory and frameworks should guide the equit...
Kristina Jenei Kristina Jenei
Policy Points The World Health Organization (WHO) Model Lists of Essential Medicines (EML) aims to select clinically beneficial and cost-effective medicines that ought to be prioritized by health systems based on the priority needs of their...
Kamaria Kaalund,Jay A Pearson,Andrea Thoumi Kamaria Kaalund
Policy Points Science communication and health policy language often fail to adequately define and contextualize systemic barriers-like structural racism and wealth inequity-that contribute to disparities in health outcomes. Health policy p...
Rena M Conti,Patrick Demartino,Jonathan Gruber et al. Rena M Conti et al.
Policy Points Cell and gene therapies (CGTs) offer treatment for rare and oftentimes deadly disease, but their prices are high, and payers may seek to limit spending. Total annual costs of covering all existing and expected CGTs for the ent...
Stephanie B Gold,Allison Costello,Maura Gissen et al. Stephanie B Gold et al.
Policy Points A redirection of measurement in health care from a narrow focus on diseases and care processes towards assessing whole person health, as perceived by the person themself, may provide a galvanizing view of how health care can b...